High‐density lipoprotein‐related cholesterol metabolism in Alzheimer's disease - Pedrini - 2021 - Journal of Neurochemistry - Wiley Online Library
Cancers | Free Full-Text | Apolipoprotein A-I (ApoA-I), Immunity, Inflammation and Cancer
Bovine apolipoprotein (apo)A-I displays more enhanced antioxidant and anti-atherosclerotic activity in lipid-free and lipid-bound states than human and porcine apoA-I
HDL (High-Density Lipoprotein) and ApoA-1 (Apolipoprotein A-1) Potentially Modulate Pancreatic α-Cell Glucagon Secretion | Arteriosclerosis, Thrombosis, and Vascular Biology
Structural Determination of Lipid-bound ApoA-I Using Fluorescence Resonance Energy Transfer - ScienceDirect
Effect of apoA-I PEGylation on the Biological Fate of Biomimetic High-Density Lipoproteins | ACS Omega
Figure 3
Schematic presentation of ApoA-I peptide interaction with lipids. (A)... | Download Scientific Diagram
Apolipoprotein A-I for Cardiac Recovery Post–Myocardial Infarction | JACC: Basic to Translational Science
Role of apoA-I, ABCA1, LCAT, and SR-BI in the biogenesis of HDL | SpringerLink
The apoB/apoA‐I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid‐lowering therapy – a review of the evidence - WALLDIUS - 2006 - Journal of Internal Medicine -
Association Between ApoA-I (Apolipoprotein A-I) Immune Complexes and Adverse Cardiovascular Events—Brief Report | Arteriosclerosis, Thrombosis, and Vascular Biology
HDL-apoA-I Exchange: Rapid Detection and Association with Atherosclerosis | PLOS ONE
JCI - Molecular regulation of HDL metabolism and function: implications for novel therapies
Frontiers | ABCA1, apoA-I, and BTN3A1: A Legitimate Ménage à Trois in Dendritic Cells
Frontiers | Structural Insights into High Density Lipoprotein: Old Models and New Facts
Biomolecules | Free Full-Text | The Role of HDL and HDL Mimetic Peptides as Potential Therapeutics for Alzheimer's Disease
The Structure of Apolipoprotein A-I in High Density Lipoproteins* - Journal of Biological Chemistry
Dietary Strategies and Novel Pharmaceutical Approaches Targeting Serum ApoA- I Metabolism: A Systematic Overview
ApoA-I Infusion Therapies Following Acute Coronary Syndrome: Past, Present, and Future | SpringerLink
Thomas Dayspring on Twitter: "CLICK: Apolipoprotein A-I produced in hepatocytes (most secreted, but some affixed to VLDL) or enterocytes (where most affixes to chylomicrons) lipidates (with PL or FREE cholesterol) and begins
Thomas Dayspring on Twitter: "CLICK: Apolipoprotein A-I produced in hepatocytes (most secreted, but some affixed to VLDL) or enterocytes (where most affixes to chylomicrons) lipidates (with PL or FREE cholesterol) and begins
Apolipoprotein AI - Wikipedia
Apolipoprotein A-I (ApoA-I) Mimetic Peptide P2a by Restoring Cholesterol Esterification Unmasks ApoA-I Anti-Inflammatory Endogenous Activity In Vivo | Journal of Pharmacology and Experimental Therapeutics
Structure of apolipoprotein A-I in spherical high density lipoproteins of different sizes | PNAS
HDL-apoA-I Exchange: Rapid Detection and Association with Atherosclerosis | PLOS ONE
Apolipoprotein A-I mimetic peptides and their role in atherosclerosis prevention | Nature Reviews Cardiology
